Financial Services

Lupin wins FDA approval for its generic dapagliflozin, a move set to slash costs for a blockbuster diabetes and heart drug and reshape patient care.

After three rejections, Outlook Therapeutics escalates its fight for US approval of a key wet AMD drug, already sold in Europe. Will the FDA bend?

Thrive's new CJIS-approved cloud hosting allows police to modernize IT while meeting strict FBI data rules, boosting security and operational resilience.

Grön's new PIXLZ gummies blend Y2K nostalgia with advanced cannabis science, aiming to reprogram the edible experience with mode-based, sensory effects.

A new independent study shows AVID Excel nearly doubles reclassification rates for long-term English learners, offering a proven path to academic success.

EIS strengthens its demolition and infrastructure services in the Mountain Region with the strategic acquisition of Utah's respected TID Demolition.

A key UN recognition for Link Engineering's tire testing methods provides critical clarity for automakers grappling with new Euro 7 non-exhaust emissions.

A new minimally invasive stent for complex aortic arch disease receives FDA approval, offering hope to high-risk patients previously deemed untreatable.

As the mortgage industry braces for the UAD 3.6 mandate, Velox Valuations announces nationwide readiness, pairing compliance with strategic tech and expansion.

With its lead cancer drug advancing and a strong balance sheet, Nurix will detail its vision for protein degradation at a key investor conference.

Early Phase 3 results show gotistobart dramatically extends survival for lung cancer patients with limited options, heralding a potential new standard of care.

Manufacturers warn new laws on AI, climate, and taxes could cripple the state's $382B industry, while proponents push for worker and climate protection.

Textron Aviation's new in-flight operable door for its SkyCourier turboprop targets military, humanitarian, and skydiving roles, boosting its versatility.

Smarter Technologies launches SmarterUtilization, an AI platform tackling the costly, manual process of utilization management. Can it fix healthcare's bottom line?

KatRisk's acquisition of RED signals a major industry shift, promising a unified multi-peril platform and accelerating the race for a new U.S. earthquake model.

A biotech firm is putting genetically engineered probiotics on bar menus. Is this the future of nightlife or a high-tech placebo for the mindful drinker?

One CEO's shift from overworked operator to visionary leader sparked a 40% revenue surge. The secret? A structured system rooted in performance science.

As lung cancer becomes a growing crisis for women, the LCRF gala honors two leaders driving change and rallying support for life-saving research.

With 86% of Gen Z seeking guidance, iMentor's "Open Doors" campaign mobilizes corporate giants to unlock one million career opportunities for young people.

With a 60-year legacy in charitable gaming, Delta's new app aims to blend community values with modern mobile play in a fiercely competitive landscape.